REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

MEDI-RADIOPHARMA Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: MEDI-RADIOPHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

medi-radiopharma co., ltd is a company with over 25 years of experience in the global supply of radiopharmaceutical products. The company focuses on research, development, manufacturing, and trade of active radiopharmaceuticals, offering services to pharmaceutical and clinical partners. medi-radiopharma co., ltd operates in the field of nuclear medicine and provides 16 different technetium cold kits used for diagnostic purposes to over 70 countries.

Headquarters
Szamos u. 10-12.
Erd; Pest; Postal Code: 2030

Contact Details: Purchase the MEDI-RADIOPHARMA Kft. report to view the information.

Website: http://www.mediradiopharma.com

Basic Information
Total Employees:
Purchase the MEDI-RADIOPHARMA Kft. report to view the information.
Registered Capital:
Purchase the MEDI-RADIOPHARMA Kft. report to view the information.
Financial Auditors:
Purchase the MEDI-RADIOPHARMA Kft. report to view the information.
Incorporation Date:
December 06, 1995
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after MEDI-RADIOPHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.83%▲
Total operating revenue
8.65%▲
Operating profit (EBIT)
2.05%▲
EBITDA
3.71%▲
Net Profit (Loss) for the Period
18.52%▲
Total assets
6.4%▲
Total equity
5.66%▲
Operating Profit Margin (ROS)
-2.41%▼
Net Profit Margin
1.25%▲
Return on Equity (ROE)
0.88%▲
Debt to Equity Ratio
-2.38%▼
Quick Ratio
-0.46%▼
Cash Ratio
-0.06%▼

Similar companies

Richter Gedeon Nyrt.
 
PHOENIX Pharma Zrt.
Egis Gyogyszergyar Zrt.
 
Teva Gyogyszergyar Zrt.
CHINOIN Zrt.
 
Novartis Hungaria Kft.
PANNONPHARMA KFT.
 
BIOEXTRA ZRt.
Vertes Plazma Kft.
 
Cf Pharma Kft.
GlaxoSmithKline Kft.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo